Dr George Vassiliou is a Cancer Research UK Senior Fellow and an Honorary Consultant Haematologist at Cambridge University Hospitals. (sanger.ac.uk)
Dr George Vassiliou, joint project leader from the Sanger Institute and Consultant Haematologist at Cambridge University Hospitals NHS Trust, said: «This research has led to the identification of many potential gene targets for future AML therapy, which we are making available to other researchers to explore. (sciencedaily.com)
The journal's contribution to advancing the field of haematology is the reason why it is read by haematologists, clinical pharmacologists, cardiologists, surgeons, internal specialists and laboratory physicians (escardio.org)